Jincai Lu

Dr. Jincai Lu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
LZLinghe Zang
Linghe Zang
FTFangyuan Tian
Fangyuan Tian
YYYuancheng Yao
Yuancheng Yao
YCYiran Chen
Yiran Chen
YSYuan Shen
Yuan Shen
JLJincai Lu
Jincai Lu
Qianliexin capsule (QLX) is a standardized traditional Chinese herbal preparation that has long been used to treat chronic non‐bacterial prostatitis (CNP) and benign prostatic hyperplasia (BPH). This study investigated the anti‐inflammatory activity of QLX in improving lower urinary tract symptoms (LUTS) associated with CNP and BPH. Rat models of CNP and BPH were induced by oestradiol or testosterone (hormonal imbalance) or chemical inflammation (carrageenan). QLX significantly relieved LUTS in CNP and BPH rat model by reducing prostate enlargement, epithelial thickness, pain response time, urine volume and bleeding time, and by improving prostatic blood flow. The expression of the pro‐inflammatory cytokines interleukin (IL)‐1β and tumour necrosis factor (TNF)‐α, the pro‐inflammatory transcription factor nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB), and inflammasome components (NLRP3, caspase‐1 and ASC) in CNP and BPH tissues was reduced by QLX addition. QLX treatment was followed by reduced cellular malondialdehyde and increased superoxide dismutase, catalase and glutathione peroxidase activity, consistent with antioxidant activity. Increases in Beclin‐1 expression and the LC3II/I ratio following QLX treatment indicated that autophagy had been induced. QLX relieved LUTS in CNP and BPH rat models by inhibiting inflammation. The underlying mechanisms included inhibition of inflammasome activation, NF‐κB activation, oxidant stress and autophagy.

1 September 2021 in Analytical Biochemistry
Verified
Journal Article
Closed access
LZLinghe Zang
Linghe Zang
YZYuwei Zhang
Yuwei Zhang
JZJing Zhao
Jing Zhao
YYYunxia Yuan
Yunxia Yuan
YWYi Wen
Yi Wen
JLJincai Lu
Jincai Lu